A professional recounts in a July 22 article the differences experienced after moving from a large pharmaceutical company to a midsize specialty pharma organization. The author describes an incident where their supply team arranged for a life-saving product transfer between hospitals, highlighting how immediate action and smaller teams can have a direct impact on patient care.
The article contrasts the structured processes and scale of large pharmaceutical companies with the more targeted and hands-on approach found in specialty pharma. The author said, "Large pharmaceutical companies are exceptional training grounds in terms of the scale of investment, the rigor of process and the breadth of therapeutic exposure." However, they note that such environments often limit individuals to specialized roles without exposure to broader decision-making.
In specialty pharma organizations, professionals engage more directly with patients and stakeholders across highly focused markets. The author said that success is determined by understanding small ecosystems in detail: "In markets such as rare disease and emergency medicine, commercial success is often less about broad reach and more about precision..."
The article emphasizes that accountability increases in smaller organizations. Processes or decisions are often owned end-to-end by individuals rather than being distributed across multiple teams. This structure encourages personal initiative, humility, and problem-solving skills over technical accomplishments alone.
Leadership expectations also shift within midsize companies. According to the author, leaders must foster environments where employees can grow quickly by taking responsibility rather than waiting for formal advancement cycles: "Your role is not to manage performance against a defined track. It is to create an environment where people can grow quickly, take real responsibility and be recognized for it." The transition allows professionals to apply foundational skills from larger firms while developing deeper expertise tailored toward specific patient populations.
